(Dan Tri) – Vinmec Health System recently announced the establishment of a research lab specialized in cellular and subcellular level osteosarcoma at Osaka Metropolitan University (OMU), Japan.
The goal of the research lab is to seek the best treatments possible by combining the advantages of OMU’s in-depth osteosarcoma research with the actual clinical treatment data from Vinmec.
Representatives of Vinmec and Osaka City University (Osaka Metropolitan University), Japan at the opening ceremony of the osteosarcoma Research Lab (Vinmec Healthcare Innovation Lab) located at OMU.
The Vinmec osteosarcoma research lab at OMU is specially designed with full range of modern equipment along with leading storage and analytical technologies for research such as PHCBI deep refrigeration; gene-level sample processing technology, next-Generation Sequencing molecule – the state-of-the-art DNA and gene sequencing technology nowadays…
With a large amount of data from Vinmec Tissue Bank and specialized technology from OMU – the works at the Research Lab offer high level of personalization, especially for the unique characteristics of Vietnamese people in particular and Asia in general. This also acts as a valuable analytic base, enabling effective treatment monitoring for patients at the moment as well as facilitating the evaluation of new methods of diagnosis and treatment in the next 5-10 years.
Following the opening ceremony, the two sides immediately held a meeting to specifically discuss about the Lab’s operation with the participation of Prof. Norifumi Kawada – Chairman, Head of Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University (OMU)
Specifically, the Research Department will have high applicability thanks to the continuous coordination activities between Vietnamese and Japanese doctors to treat patients undergoing treatment at Vinmec. After each course, biological products will be sent to Japan for analysis, from which the doctor refines the regimen such as increasing/decreasing the dose of chemotherapy, oral drugs, etc., in accordance with each person’s progress in order to achieve the goal. highest efficiency.
Vinmec osteosarcoma Intensive Research Laboratory was developed and co-developed by Assoc. Prof. MD. Le Thi Thanh Thuy from the School of Medicine (OMU) and Professor Tran Trung Dung – Director of Vinmec Center for Traditional Medicine & Traditional Medicine, cum visiting professor at OMU. Director, operating activities and chairing related projects.
Prof. MD. Tran Trung Dung – Director of Orthopaedic and Sports Medicine Center, visiting professor of OMU, co-director of Vinmec Healthcare Innovation Lab, introduced about Vinmec Healthcare System and VinUniversity to Japanese professors at OMU.
Participating in the research guiding are leading Japanese oncology experts who are also faculty members at universities such as: Prof. Norifumi Kawada – Chairman, Head of Department of Hepatology, Graduate School of Medicine (OMU); Prof. Hisashi Motomura – Graduate School of Medicine, Department of Clinical Medical Science, School of Medichine, Chairman of the International Cooperation Committee, Department of Plastic and Reconstructive Surgery (OMU); Professor Daisuke Tsuruta – Head of the Department of Cosmetic Dermatology, Undergraduate and Graduate School of Medicine (OMU)….
Research fellows include doctors from Vinmec Center for Orthopedic Trauma and Sports Medicine
Prof. Tran Trung Dung, Co-Director of the Research Lab in Japan, indicated: “Basic research helps the clinician’s hands and eyes to reach deeply at the cellular and subcellular levels of the process. Only with more in-depth fundamental research at this level can osteosarcoma treatment outcomes be tracked on an ongoing basis. This practice is also in the direction of personalization in precision medichine that Vinmec is pursuing”.
Congratulating the research and training cooperation project between the two parties, Prof. Norifumi Kawada also affirmed: “This will be an effective bridge for clinical treatment and fundamental scientific research, contributing to the actual treatment for our patients. We hope that the new project will help create an bigger picture about osteosarcoma issues in Vietnam and facilitate the improvement of patient care services.”
The first Japanese experts and Vietnamese researchers will participate in the intensive research program on osteosarcoma at Vinmec Healthcare Innovation Lab, which is expected to bring new breakthroughs and remedies to improve quality of life for the patient.
The establishment of the osteosarcoma Research Lab is part of a research cooperation plan between Vinmec Health System (Vietnam) and Osaka Metropolitan University (Japan) recently signed.
The course of studying and researching at Osaka City University will open up opportunities for Vinmec’s team of orthopedic surgeons to improve their independent scientific research capability – one of the core factors for human resources in a Center of Excellence (COE) as defined by Vinmec Health System’s current academic direction.
To book an appointment, please dial HOTLINE or book directly HERE. Download and book an automatic appointment on the MyVinmec application to manage, track the schedule and book an appointment anytime, anywhere.
About Osaka Metropolitan University (OMU)
OMU is one of Japan’s oldest universities with a history of nearly 150 years. Ranked among the top 3 out of 744 Japan’s universities, OMU is leading in terms of post-training staff calibre, which is evaluated by scientific research standards. Annually, the school welcomes and trains nearly 10,000 students, including about 500 international students. In particular, the University’s Hospital and Graduate School of Medicine have just been become the world’s top ranker on two specialization: Orthopedic Trauma and Radiation Oncology. The hospital has an area of 87,000 m2, with 900 beds and regularly admits and treats more than 2,000 outpatients daily.
Website: https://www.med.osaka-cu.ac.jp/
Newsweek’s resource for the World’s Best Hospital for Orthopedic Trauma: Best Specialized Hospitals 2022 – Orthopedics (newsweek.com))
Sarcoma is a rare yet highly malignant group of cancers, with bone cancer and soft tissue cancer being two groups that require complex diagnostic and treatment processes. Soon, patients in Vietnam will gain access to a new reputable facility for comprehensive sarcoma treatment that has been evaluated by Cleveland Clinic (USA).
Bone and soft tissue cancer (sarcoma) is a rare form of highly malignant, easily misdiagnosed cancer that requires complicated treatment - a host of challenges that make its treatment in Vietnam remains a big gap. This situation leads to remarkable disadvantages for the majority of patients.
The prevalence of heart failure in the Southeast Asia region is significantly higher than the rest of the world (4.5–6.7% compared to 0.5–2%) [1]. In the case of cardiac hospitals in Vietnam, heart failure patients account for 15% of total admissions, with a readmission rate within 30 days after discharge rising up to 7% [2].
Recently, the conference on Quality Assurance Team for Radiation Oncology (QUATRO) took place at Vinmec Central Park International General Hospital, attracting many experts and leaders from leading Oncology hospitals across the country. The conference aims to discuss safety requirements, as well as quality assurance standards in radiotherapy practice.
